Financials
- Market Capitalization 10.73 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.21
Rapporto prezzo/fatturato
16.08
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 822 | TECH Bio-Techne Corp - Common Stock | 72.56 USD | +0.14% | -0.03% | +0.48% | +23.55% | 11.38 B USD | ||
| 848 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 467.16 USD | -0.97% | -6.02% | -13.49% | +10.28% | 10.79 B USD | ||
| 852 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 55.39 USD | +1.08% | -3.74% | -16.71% | +6.97% | 10.72 B USD | ||
| 868 | PCVX Vaxcyte, Inc. - Common Stock | 70.65 USD | -1.02% | -3.68% | +17.67% | +67.02% | 10.51 B USD |